Lipoplus (Omega-3-Acid Triglycerides, Soya-Bean Oil Refined, Triglycerides, Medium Chain)

The omega‑3‑acid triglycerides in Lipoplus are hydrolyzed by lipoprotein lipase after infusion, releasing free fatty acids that are oxidized for energy and incorporated into cell membranes. This process supplies both caloric energy and essential fatty acids needed for membrane synthesis, inflammatory modulation, and overall metabolic support.

The dose of Lipoplus is individualized by the prescribing clinician based on the patient’s caloric needs, weight, and clinical condition. Dosing calculations consider total energy requirements, existing lipid intake, and laboratory parameters such as triglyceride levels.

Safety data for Lipoplus in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician in consultation with obstetric specialists.

To order Lipoplus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.

Lipoplus distinguishes itself by combining omega‑3‑acid triglycerides, refined soybean oil and medium‑chain triglycerides, offering a balanced profile of omega‑3, omega‑6 and medium‑chain fatty acids. Compared with emulsions based solely on soybean or olive oil, Lipoplus may provide additional anti‑inflammatory benefits and a broader range of fatty acids for membrane synthesis.

Lipoplus must be stored at 2‑8 °C in a refrigerator. Keep the container in its original packaging, protect it from light, and avoid freezing or shaking the emulsion. Before use, allow the product to reach room temperature if required by the administration protocol.

Lipoplus is administered intravenously, typically as part of a total parenteral nutrition regimen. It is infused through a dedicated lumen or a compatible IV line, following the infusion rate recommended by the prescribing clinician to minimize the risk of fat overload and related complications.

Serious risks include anaphylactic reactions, severe hypertriglyceridemia leading to pancreatitis, liver dysfunction with marked enzyme elevation, coagulopathy, and rare events such as pulmonary embolism. Continuous monitoring of vital signs, triglyceride levels, liver function tests and coagulation parameters is essential during therapy.

Lipoplus should be avoided in patients with known hypersensitivity to any of its components (soybean oil, fish oil, or medium‑chain triglycerides), uncontrolled hypertriglyceridemia, severe liver disease, or in those for whom a lipid‑free parenteral nutrition regimen is clinically indicated.